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Supplementary Figure S1 . HPLC-DAD Analysis. HPLC-DAD chromatograms of bilirubin standard (10nM, red line) and endothelial cellular fraction (blue line). Co-elution of both HPLC peaks additionally proved the presence of IXα bilirubin in the sample. Comparison between absorbance spectra (using peak purity function by the DAD detector), which were taken in the 2 area across a chromatographic peak of analyzed bilirubin standard solution and the peak present in the sample from the control group is shown in Figure 2b .
Limit of detection (LOD) and limit of quantification (LOQ) were determined using the peak representing bilirubin based on a visual determination of a peak-to-peak signal-to-noise ratio of at least 3:1 and 10:1, respectively. The detector coupled to the HPLC system, i.e. either one based on TLS or a DAD, determines the detection and quantification performance of the methods, as detailed in Supplementary Table 1 . 
High Resolution

UPLC-MS analysis of a sample of endothelial cells without pre-concentration
The bilirubin signal intensity (m/z of 583.3) in the analyzed sample (from the control group) was almost insignificant (under LOD) as shown in Supplementary Figure S1 .
Supplementary Figure S3 . UPLC-MS analysis of the sample (from the control group) without pre-concentration, using the flow rate of 0.5 mL/min in order to increase the ionization yield in ESI source due to lower amount of mobile phase that passes through the ion source. No peak detection was observed without pre-concentration. The signal marked with black arrow corresponds to m/z value of 583.2 (+/-0.2).
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